Tylenol-maker Kenvue on Thursday beat Wall Street estimates for first-quarter revenue and profit helped by strong sales in its skin health and beauty brands.
Culture. Cinema. Style.Magazine
THE SMSA NEWS APPYour world. Wherever you are.Discover the app ↗↗



